HEAL.L vs. LLY
HEAL.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) is Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while LLY (Eli Lilly and Company) is a stock. Over the past 5 years, HEAL.L returned -1.96%/yr vs 42.32%/yr for LLY. At a 0.20 correlation, their price movements are largely independent.
Performance
HEAL.L vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HEAL.L achieves a 0.64% return, which is significantly lower than LLY's 5.06% return.
HEAL.L
- 1D
- 3.48%
- 1M
- 4.82%
- YTD
- 0.64%
- 6M
- -0.41%
- 1Y
- 20.32%
- 3Y*
- 6.08%
- 5Y*
- -1.96%
- 10Y*
- —
LLY
- 1D
- 4.31%
- 1M
- 13.99%
- YTD
- 5.06%
- 6M
- 11.30%
- 1Y
- 47.97%
- 3Y*
- 37.29%
- 5Y*
- 42.32%
- 10Y*
- 33.27%
HEAL.L vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HEAL.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 0.64% | 18.42% | 0.96% | 3.11% | -24.00% | -6.52% | 54.05% | 12.43% | -3.45% | 35.92% |
LLY Eli Lilly and Company | 5.06% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Correlation
The correlation between HEAL.L and LLY is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2016 | 0.20 |
The correlation between HEAL.L and LLY shifts across timeframes, from 0.19 (5 years) to 0.31 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEAL.L vs. LLY — Risk / Return Rank
HEAL.L
LLY
HEAL.L vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HEAL.L | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | -0.04 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.25 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.61 | 2.04 | -0.43 |
| Martin ratioReturn relative to average drawdown | 3.96 | 5.07 | -1.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HEAL.L | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 1.27 | -0.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | 1.30 | -1.39 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.11 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.58 | -0.25 |
Drawdowns
HEAL.L vs. LLY - Drawdown Comparison
The maximum HEAL.L drawdown since its inception was -46.43%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for HEAL.L and LLY.
Loading charts...
Drawdown Indicators
| HEAL.L | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.43% | -68.24% | +21.81% |
Max Drawdown (1Y)Largest decline over 1 year | -12.59% | -23.64% | +11.05% |
Max Drawdown (3Y)Largest decline over 3 years | -21.46% | -34.48% | +13.02% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -34.48% | -9.22% |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | -20.00% | -0.14% | -19.86% |
Average DrawdownAverage peak-to-trough decline | -18.60% | -19.22% | +0.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.12% | 9.49% | -4.37% |
Volatility
HEAL.L vs. LLY - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) is 5.13%, while Eli Lilly and Company (LLY) has a volatility of 9.76%. This indicates that HEAL.L experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEAL.L | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.13% | 9.76% | -4.63% |
Volatility (6M)Calculated over the trailing 6-month period | 13.28% | 27.11% | -13.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.48% | 38.11% | -20.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.87% | 32.84% | -12.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.91% | 30.17% | -10.26% |
Dividends
HEAL.L vs. LLY - Dividend Comparison
HEAL.L has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.57%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEAL.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.57% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Frequently Asked Questions
HEAL.L and LLY have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for HEAL.L and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer